Classification of molecular subtypes based on the expression of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and proliferation levels also helps predicting recurrence patterns and tailoring more personalized therapy for BC patients.6, 7. Here, ERBB2 is linked to breast cancer.